{
  "id": "LAB-HEME-HGB-002",
  "name": "Policitemia Critica",
  "category": "LAB",
  "subcategory": "HEMATOLOGY",
  "description": "Alerta para hematocrito >52% ou hemoglobina >18.5 g/dL com risco de hiperviscosidade e trombose",
  "version": "1.0.0",
  "created": "2026-02-06",
  "updated": "2026-02-06",
  "author": "Critical Lab Specialist",
  "status": "active",
  "priority": "CRITICAL",
  "clinicalRationale": "Hematocrito >60% causa sindrome de hiperviscosidade com alto risco de trombose. Policitemia vera (JAK2+) requer meta de Hct <45% para reduzir eventos cardiovasculares (CYTO-PV trial). Flebotomia e tratamento eficaz em emergencia.",
  "inputVariables": [
    {
      "name": "hemoglobina",
      "type": "number",
      "unit": "g/dL",
      "description": "Hemoglobina",
      "required": false
    },
    {
      "name": "hematocrito",
      "type": "number",
      "unit": "%",
      "description": "Hematocrito",
      "required": false,
      "normalRange": "36-44% (mulheres), 40-50% (homens)"
    }
  ],
  "outputVariables": [
    {
      "name": "nivelAlerta",
      "type": "string",
      "values": ["Alerta", "Atencao", "OK"]
    },
    {
      "name": "urgencia",
      "type": "string",
      "values": ["IMEDIATA", "ALTA", "MEDIA", "BAIXA"]
    },
    {
      "name": "classificacao",
      "type": "string"
    },
    {
      "name": "tendencia",
      "type": "string"
    },
    {
      "name": "acaoRequerida",
      "type": "string"
    },
    {
      "name": "justificativaCientifica",
      "type": "string"
    }
  ],
  "references": [
    "WHO Criteria: Polycythemia Vera Diagnosis",
    "CYTO-PV Trial: Hematocrit Control in PV",
    "Critical Lab Values: Hematocrit >60% requires immediate notification"
  ],
  "tags": ["critical-lab", "hematology", "polycythemia", "hyperviscosity", "JAK2", "thrombosis"]
}
